Hepatitis B surface antigen presentation and HLA-DRB1* - Lessons from twins and peptide binding studies

Clinical and Experimental Immunology

Volumn 140, Issue 2, 2005, Pages 325-332

  Kruger, Anke ^a   Adams, P ^a   Hammer, J ^b   Bocher W O ^a   Schneider, P M ^a   Rittner, C ^a   Hoehler, T ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

HBsAg; HLA DR; Peptide presentation; T cell response

Indexed keywords

CYTOKINE; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B SURFACE ANTIGEN; HLA DR ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIZYGOTIC TWINS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; GENETIC ASSOCIATION; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE CLONE; MAJOR CLINICAL STUDY; MONOZYGOTIC TWINS; PRIORITY JOURNAL; PROTEIN BINDING; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TREATMENT FAILURE; TWINS; VACCINATION;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ANTIGEN PRESENTATION; BINDING, COMPETITIVE; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HLA-DR ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MIDDLE AGED; MOLECULAR SEQUENCE DATA; TH1 CELLS; TWINS;

EID: 17644416831     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02765.x     Document Type: Article

References (23)

1. Whittle H, Jaffar S, Wansbrough M, Mendy M, Dumpis U, Collinson A, Hall A. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. Br Med J 2002; 325:569.
2. Craven DE, Awdeh ZL, Kunches LM et al. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med 1986; 105:356-60.
3. Alper CA. The human immune response to hepatitis B surface antigen. Exp Clin Immunogenet 1995; 12:171-81.
4. Hohler T, Reuss E, Evers N et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 2002; 360:991-5.
5. Alper CA, Kruskall MS, Marcus-Bagley D et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989; 321:708-12.
6. Desombere I, Willems A, Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 1998; 51:593-604.
7. Hohler T, Meyer CU, Notghi A et al. The influence of major histocompatibility complex class II genes and T- cell Vbeta repertoire on response to immunization with HBsAg. Hum Immunol 1998; 59:212-8.
8. Lahgo-Warensjo A, Cardell K, Lindblom B. Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response after immunisation with hepatitis B surface antigen. Tissue Antigens 1998; 52:374-80.
9. Desombere I, Hauser P, Rossau R, Paradijs J, Leroux-Roels G. Non-responders to hepatitis B vaccine can present envelope particles to T lymphocytes. J Immunol 1995; 154:520-9.
10. Salazar M, Deulofeut H, Granja C et al. Normal HBsAg presentation and T-cell defect in the immune response of nonresponders. Immunogenetics 1995; 41:366-74.
11. Bein G, Glaser R, Kirchner H. Rapid HLA-DRB1 genotyping by nested PCR amplification. Tissue Antigens 1992; 39:68-73.
12. Sinigaglia F, Romagnoli P, Guttinger M, Takacs B, Pink JR. Selection of T cell epitopes and vaccine engineering. Meth Enzymol 1991; 203:370-86.
13. Hammer J. New methods to predict MHC-binding sequences within protein antigens. Curr Opin Immunol 1995; 7:263-9.
14. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997; 27:3135-42.
15. Honorati MC, Dolzani P, Mariani E, Piacentini A, Lisignoli G, Ferrari C, Facchini A. Epitope specificity of Th0/Th2 CD4+ T-lymphocyte clones induced by vaccination with rHBsAg vaccine. Gastroenterology 1997; 112:2017-27.
16. Celis E, Ou D, Otvos L Jr. Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides. J Immunol 1988; 140:1808-15.
17. Desombere I, Gijbels Y, Verwulgen A, Leroux-Roels G. Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines. Clin Exp Immunol 2000; 122:390-9.
18. Watanabe H, Okumura M, Hirayama K, Sasazuki T. HLA-Bw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis-B surface antigen via CD8-positive suppressor T cells. Tissue Antigens 1990; 36:69-74.
19. Soroosh P, Shokri F, Azizi M, Jeddi-Tehrani M. Analysis of T-cell receptor beta chain variable gene segment usage in healthy adult responders and nonresponders to recombinant hepatitis B vaccine. Scand J Immunol 2003; 57:423-31.
20. Barnaba V, Franco A, Alberti A, Benvenuto R, Balsano F. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature 1990; 345:258-60.
21. De Silvestri A, Pasi A, Martinetti M, Belloni C, Tinelli C, Rondini G, Salvaneschi L, Cuccia M. Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus. Genes Immun 2001; 2:367-72.
22. Hohler T, Stradmann-Bellinghausen B, Starke R, Sanger R, Victor A, Rittner C, Schneider PM. C4A deficiency and nonresponse to hepatitis B vaccination. J Hepatol 2002; 37:387-92.
23. Milich DR. Influence of C4A deficiency on nonresponse to HBsAg vaccination: a new immune response gene. J Hepatol 2002; 37:396-9.